去年，Lifecore Biomedical Inc表现最佳的业务板块Contract development and manufacturing organization ("CDMO")实现营收86.31M美元。United States的营收贡献最高，去年达到145.79M美元。最近一个季度，截至2026-06-30，Lifecore Biomedical Inc表现最佳的业务板块HA manufacturing实现营收18.61M美元。United States的营收贡献最高，达到16.40M美元。

业务

营业收入

占比

年报

年报

单季报

Contract development and manufacturing organization ("CDMO")

Avocado products

Fermentation

Olive oil and wine vinegars

Technology

Fresh packaged salads and vegetables

FY2022

FY2021

FY2020

FY2019

Contract development and manufacturing organization ("CDMO")

86.31M(46.46%)

75.30M(43.89%)

64.78M(10.97%)

54.44M(9.76%)

Avocado products

65.27M(35.13%)

63.58M(37.06%)

62.19M(10.53%)

27.32M(4.90%)

Fermentation

23.01M(12.38%)

22.79M(13.29%)

21.05M(3.57%)

21.43M(3.84%)

Olive oil and wine vinegars

9.29M(5.00%)

7.59M(4.42%)

--(--)

Technology

1.91M(1.03%)

2.29M(1.34%)

4.26M(0.72%)

1.18M(0.21%)

Fresh packaged salads and vegetables

--(--)

438.08M(74.21%)

453.18M(81.28%)

地区

营业收入

占比

年报

年报

单季报

United States

Switzerland

Canada

Czech Republic

United Kingdom

Ireland

All OTHER Countries

Belgium

All Other Countries

Mexico

FY2022

FY2021

FY2020

FY2019

FY2018

United States

145.79M(78.47%)

--(--)

Switzerland

16.80M(9.04%)

4.70M(12.88%)

--(--)

800.00K(0.78%)

Canada

12.60M(6.78%)

10.70M(29.32%)

76.40M(74.90%)

83.60M(76.84%)

78.00M(75.80%)

Czech Republic

3.50M(1.88%)

3.50M(9.59%)

--(--)

United Kingdom

2.90M(1.56%)

--(--)

800.00K(0.78%)

Ireland

2.20M(1.18%)

2.00M(5.48%)

4.00M(3.92%)

5.00M(4.60%)

4.10M(3.98%)

All OTHER Countries

2.00M(1.08%)

1.90M(5.21%)

7.80M(7.65%)

5.10M(4.69%)

--(--)

Belgium

--(--)

13.70M(37.53%)

13.80M(13.53%)

15.10M(13.88%)

17.20M(16.72%)

All Other Countries

--(--)

1.40M(1.36%)

Mexico

--(--)

600.00K(0.58%)